XLS《Sheet1》

"100g:5g","9101", ,,

"100g:10g","9102", "20","精制马拉硫磷溶液(水产用)","100g:20g","9103","本品的杀虫效果不及拟除虫菊酯,本品缺乏对环境和食品安全性影响的数据,不予转正" "21","精制敌百虫粉(水产用)","0.900000610351563","9038","80%、90%规格太接近,90%厂家只有2家,删除90%规格" "22","盐酸大观霉素、盐酸林可霉素注射液",,

,"该复方制剂改变给药途径(口服给药改为注射给药)缺乏依据","" "23","硫酸新霉素、盐酸多西环素可溶性粉",,

,"该组方缺乏支持" "24","复方硫氰酸红霉素可溶性粉",,

,"未按665公告要求修订含量测定方法" "25","复方磺胺嘧啶钠溶液",,

,"未按标准处方组织生产原申报资料、转正资料和企业现场提供传真资料中生产处方不同" "26","马度米星铵溶液",,

,"申报资料缺少靶动物安全性数据,不能保证用药安全" "27","葡萄糖酸钙溶液",,

,"葡萄糖酸钙溶解度低,无法生产30%的溶液" "28","复合阿司匹林可溶性粉",,

,"阿司匹林在碱性溶液中不稳定;

配方中的药物相互反应;

阿司匹林治疗痛风的疗效不明确" "29","复方乌洛托品可溶性粉",,

,"组方不合理" "30","复方诺氟沙星可溶性粉",,

,"组方无依据" "31","乌洛托品可溶性粉",,

,"

1、没有临床试验支持治疗鸡尿路感染;

2、药理作用不支持促进尿酸排泄的作用" "32","枸橼酸钾、碳酸氢钠可溶性粉",,

,"适应症不明确" "33","酒石酸泰乐菌素、盐酸多西环素颗粒",,

,"有效性和安全性无相关试验和资料支持,组方依据不足" "34","酒石酸泰乐菌素、盐酸多西环素可溶性粉",,

,"有效性和安全性无相关试验和资料支持,组方依据不足" "35","敌百虫、辛硫磷粉",,

,"组方不合理,用法不科学" "36","聚甲醛、苯甲酸粉",,

,"无企业申报,废止" "37","阿莫西林注射液",,

,"有效性和用法用量无足够数据支持" "38","伊维菌素、芬苯达唑预混剂",,

,"有效性、安全性、给药方法的合理性没有足够的数据支持" "39","盐酸土霉素、延胡索酸泰妙菌素可溶性粉",,

,"国外批准的配方是金霉素和延胡索酸泰妙菌素复方,盐酸土霉素和延胡索酸泰妙菌素组方无依据" "40","硫酸小檗碱可溶性粉",,

,"临床有效性不能保证,废止" "41","盐酸左旋咪唑擦剂",,

,"无企业申报,废止" "42","碳酸氢钠、氯化钾粉",,

,"无企业申报,废止" "43","甲基对硫磷粉(蚕用)",,

,"废止" "44","盐酸氨丙啉、盐酸诺氟沙星可溶性粉",,

,"没有企业提出转正申请,也未送样复核","" "45","盐酸氨丙啉颗粒",,

,"没有企业提出转正申请,也未送样复核" "46","甲硝唑可溶性粉",,

,"该产品用于治疗禽组织滴虫病,休药期定为28日农业部第235号公告规定在所有食品动物、所有可食组织中不得检出甲硝唑,存在食品安全风险,建议不予转正" "47","葡醛内酯、维生素C可溶性粉",,

,"适应症不明确,建议不予转正" "48","盐酸小檗碱颗粒",,

,"依据现有的临床资料不能确保临床治疗效果,建议不予转正" "49","盐酸左旋咪唑可溶性粉",,

,"临床试验报告不能说明本品免疫增强剂的作用,且用法与用量不明确,建议不予转正" "50","阿维菌素、碘醚柳胺片",,